findmyKOL
Clinical trialNCT03285152CompletedInterventional

A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients

SponsorMemorial Sloan Kettering Cancer CenterEnrollment19Endometrial Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test any good and bad effects of an experimental diet, called a ketogenic diet, in endometrial cancer. A ketogenic diet is one that is very low in carbohydrates (simple and complex sugars). The goal of this diet is for the body to go into a state of ketosis. Ketosis is when the body does not have enough sugar for energy so it burns stored fats which create acids called ketones, which can be used for energy. Researchers hope to learn whether or not a ketogenic diet is well-tolerated and safe to eat before surgery in endometrial cancer patients.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Memorial Sloan Kettering Basking Ridge (consent and Follow Up)

    Basking Ridge, New Jersey, United States

  • Memorial Sloan Kettering Monmouth (consent and Follow-Up Only)

    Middletown, New Jersey, United States

  • Memorial Sloan Kettering Bergen (consent and Follow Up)

    Montvale, New Jersey, United States

  • Memorial Sloan Kettering Cancer Center @ Commack (consent and Follow Up)

    Commack, New York, United States

  • Memorial Sloan Kettering Westchester (consent & Follow Up)

    Harrison, New York, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • New York Weill Cornell Cancer Center at Cornell University

    New York, New York, United States

  • Memorial Sloan Kettering Nassau (consent and Follow-Up)

    Rockville Centre, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Feb 2018
Primary completion
24 Jun 2026
Completion
24 Jun 2026
Last update posted
29 Jun 2026
Registered enrollment
19
Registry id
NCT03285152
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.